SL-25.1188 chemical structure
Chemical structureResearch use only
CAT. NO. DC60607Featured

SL-25.1188

Pack Sizes & Prices

TotalUS$450
We match the best price and quality on market.
Product overview

Description & Application

SL-25.1188 is a reversible MAO-B inhibitor with high brain uptake and slow plasma metabolism, making it a promising candidate for treating Alzheimer's dementia and aiding in smoking cessation. Its ability to modulate neurotransmitter levels in the brain positions it as a valuable therapeutic tool for addressing these challenging conditions.

ParameterValue
Chemical NameSL-25.1188
CAS No.185835-97-6
Synonyms2-Oxazolidinone,5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzisoxazol-3-yl]-, (5S)-;(5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one;SL251188;2-Oxazolidinone,5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzisoxazol-3-yl]-, (S)-;AG-E-35045;cc-360;CTK4D9074;RL02360;SureCN7377168;(5S)-5-(METHOXYMETHYL)-3-[6-(4,4,4-TRIFLUOROBUTOXY)-1,2-BENZOXAZOL-3-YL]-1,3-OXAZOLIDIN-2-ONE;2-Oxazolidinone, 5-(methoxymethyl)-3-(6-(4,4,4-trifluorobutoxy)-1,2-benzisoxazol-3-yl)-, (5S)-;PD117914;J-501623;DTXSID00430924;AKOS040749516;SCHEMBL7377168;(5S)-5-(Methoxymethyl)-3-(6-(4,4,4-trifluorobutoxy)-1,2-benzisoxazol-3-yl)-2-oxazolidinone;(S)-5-(methoxymethyl)-3-(6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl)oxazolidin-2-one;CS-0066244;CHEMBL3354977;SQMNCLANJWZZOG-NSHDSACASA-N;BDBM50041003;SL-25.1188;HY-117502;UNII-A8C48J5JCP;185835-97-6;2-Oxazolidinone, 5-(methoxymethyl)-3-(6-(4,4,4-trifluorobutoxy)-1,2-benzisoxazol-3-yl)-, (S)-;A8C48J5JCP;SL-251188
FormulaC16H17F3N2O5
M.Wt374.31
SMILESCOCC1OC(=O)N(C2=NOC3C=C(C=CC2=3)OCCCC(F)(F)F)C1
Purity98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

SL-25.1188 is a reversible MAO-B inhibitor with high brain uptake and slow plasma metabolism, making it a promising candidate for treating Alzheimer's dementia and aiding in smoking cessation. Its ability to modulate neurotransmitter levels in the brain positions it as a valuable therapeutic tool for addressing these challenging conditions.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheetRequest COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

HYNIC-FAPI-04 chemical structureDC65513

HYNIC-FAPI-04

HYNIC-FAPI-04 is a useful ligand for making [99mTc]Tc-HYNIC-FAPI-04. In vitro experiments, the results indicated that [99mTc]Tc-HYNIC-FAPI-04 showed binding properties, and inhibited the migration of tumor cells. The…

View activity & prices
PSMA-617 Linker chemical structureDC33611

PSMA-617 Linker

Vipivotide tetraxetan Ligand-Linker Conjugate (PSMA-617 Ligand-Linker Conjugate) is composed of a linker and Glutamate-urea-Lysine, can be used to synthesize Vipivotide tetraxetan (PSMA-617). Glutamate-urea-Lysine is…

View activity & prices
MC1 chemical structureDC65841

MC1

MC1 is a selective and potent COX-2 inhibitor, and its radiolabeled form, ¹¹CMC1, is a promising PET radiotracer for detecting COX-2 expression in vivo. Its ability to visualize COX-2 in neuroinflammation and other…

View activity & prices
MC1 Precursor chemical structureDC65839

MC1 Precursor

Precursor of MC1, is a vital component in the synthesis of MC1, a selective and potent COX-2 inhibitor. Radiolabeled MC1, ¹¹CMC1, serves as a promising PET radioligand for imaging COX-2 expression in vivo. Its high…

View activity & prices
PS-13 precursor 19 chemical structureDC65709

PS-13 precursor 19

PS-13 Precursor 19 is a critical intermediate in the synthesis of PS-13, a highly potent and selective COX-1 inhibitor. PS-13's exceptional selectivity for COX-1 over COX-2 makes it a promising compound for both…

View activity & prices
PS13 chemical structureDC65710

PS13

PS13 is a highly potent COX-1 inhibitor (IC50=1 nM) and 1,000 times more selective for COX-1 than COX-2 (7). In non-human primates, 11C-PS13 showed selective binding to COX-1 over COX-2 in most major organs including…

View activity & prices
DesMEM AZD4694 chemical structureDC60790

DesMEM AZD4694

DesMEM AZD4694（AZD4694 Precursor 1）is the precursor of 18F AZD4694 for the synthesis of 18F AZD4694, an amyloid-β imaging ligand with high affinity for amyloid-β plaques.

View activity & prices
NOP-1A Precursor chemical structureDC67547

NOP-1A Precursor

The Precursor of NOP-1A. (11)C-NOP-1A is a useful radioligand for quantifying NOP receptors in the monkey brain, and its radiation dose is similar to that of other (11)C-labeled ligands for neuroreceptors.

View activity & prices
NOP-1A chemical structureDC67548

NOP-1A

NOP-1A standard. 11C-NOP-1A is a new radioligand for thenociceptin/orphanin FQ peptide (NOP) receptor, with high affinity (Ki, 0.15 nM) and appropriate lipophilicity (measured logD, 3.4) for PET brain imaging.…

View activity & prices

Cart

Request quotation